121 related articles for article (PubMed ID: 27005996)
1. Angioedema with renin angiotensin system drugs and neutral endopeptidase inhibitors.
Kostis JB; Moreyra AE; Kostis WJ
J Am Soc Hypertens; 2016 May; 10(5):387-9. PubMed ID: 27005996
[No Abstract] [Full Text] [Related]
2. Combined neutral endopeptidase inhibitors.
Cuculi F; Erne P
Expert Opin Investig Drugs; 2011 Apr; 20(4):457-63. PubMed ID: 21323474
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin-aldosterone system inhibitors in heart failure.
Shearer F; Lang CC; Struthers AD
Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
[TBL] [Abstract][Full Text] [Related]
4. Multitarget cardiovascular drugs.
Trstenjak U; Kikelj D
Curr Med Chem; 2011; 18(17):2531-42. PubMed ID: 21568894
[TBL] [Abstract][Full Text] [Related]
5. Enzyme inhibitors of the renin-angiotensin system.
Antonaccio MJ; Wright JJ
Prog Drug Res; 1987; 31():161-91. PubMed ID: 3326029
[No Abstract] [Full Text] [Related]
6. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
7. Angioedema induced by cardiovascular drugs: new players join old friends.
Bas M; Greve J; Strassen U; Khosravani F; Hoffmann TK; Kojda G
Allergy; 2015 Oct; 70(10):1196-200. PubMed ID: 26119220
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure.
Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S
Blood Press; 2012 Dec; 21(6):329-30. PubMed ID: 23210746
[No Abstract] [Full Text] [Related]
9. The natriuretic peptide neurohormonal system modulation by vasopeptidase inhibitors--the novel therapeutical approach of hypertension treatment.
Machowska A; Juszczak K; Novak P; Thor P
Folia Med Cracov; 2009; 50(3-4):35-42. PubMed ID: 21853869
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system inhibitors and angioedema: anesthetic implications.
Stojiljkovic L
Curr Opin Anaesthesiol; 2012 Jun; 25(3):356-62. PubMed ID: 22552531
[TBL] [Abstract][Full Text] [Related]
11. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
12. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.
Win TS; Chaiyakunapruk N; Suwankesawong W; Dilokthornsakul P; Nathisuwan S
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):227-35. PubMed ID: 26342120
[TBL] [Abstract][Full Text] [Related]
13. Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure.
Packer M; McMurray JJV
Lancet; 2017 May; 389(10081):1831-1840. PubMed ID: 27919443
[TBL] [Abstract][Full Text] [Related]
14. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
15. [Alternative pathways for the activation of the renin-angiotensin system].
Gurzu B; Costuleanu M; Petrescu G
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):710-7. PubMed ID: 14756007
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system blockers increase risk of angio-oedema.
Volpe M; Tocci G
Evid Based Med; 2013 Dec; 18(6):e52. PubMed ID: 23635842
[No Abstract] [Full Text] [Related]
17. A computational approach to the study of the binding mode of dual ACE/NEP inhibitors.
Dimitropoulos N; Papakyriakou A; Dalkas GA; Sturrock ED; Spyroulias GA
J Chem Inf Model; 2010 Mar; 50(3):388-96. PubMed ID: 20170101
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
Azizi M; Bissery A; Peyrard S; Guyene TT; Ozoux ML; Floch A; Ménard J
Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors.
Makani H; Messerli FH; Romero J; Wever-Pinzon O; Korniyenko A; Berrios RS; Bangalore S
Am J Cardiol; 2012 Aug; 110(3):383-91. PubMed ID: 22521308
[TBL] [Abstract][Full Text] [Related]
20. Angioedema related to Angiotensin inhibitors.
Knecht SE; Dunn SP; Macaulay TE
J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
